Calyxo
PrivateLast Round
Series F
Apr 14, 2026
Total Funding Raised
$137.25M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Calyxo is a medical device company that develops a vacuum-assisted retrieval device for the efficient removal of kidney stone fragments, allowing for the extraction of multiple fragments in a single insertion and achieving exceptional stone-free results in a streamlined procedure.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Calyxo Comparables
Compare Calyxo with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cortex, Inc. | 80% | |
| Well Lead Med Co Ltd | 77% | |
| Olympus | 75% | |
Calyxo Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series F | Apr 14, 2026 | ||||
| Series D | Dec 12, 2023 | ||||
| Series C | Jul 6, 2022 | ||||
| Series B | Oct 15, 2019 | ||||
| Series A | Aug 16, 2018 | ||||
Seed | Mar 29, 2016 |
Calyxo Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Series F |
| Ally Bridge Group | Series F |
| Questa Capital | Series D, Series B, Series F, Series C |
| Avidity Partners Management | Series D |
| Avidity Partners | Series D |
| CRG | Series D, Series F, Series C |
| VIC Technology Venture Development | Series A, Seed, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 21, 2026
Grew 17% QoQ, from 325 to 380 employees.
- Jun 26, 2026
Grew 17% QoQ, from 309 to 361 employees.
Calyxo Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Calyxo's valuation, stock price, and market status.